Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL PATIENT SIMULATORS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL PATIENT SIMULATORS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.11 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL PATIENT SIMULATORS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 PREMIUM INSIGHTS
3.1 PESTEL ANALYSIS
3.2 PORTER’S FIVE FORCES MODEL
4 INDUSTRY INSIGHTS
4.1 MICRO AND MACRO ECONOMIC FACTORS
4.2 PENETRATION AND GROWTH PROSPECT MAPPING
4.3 KEY PRICING STRATEGIES
4.4 INTERVIEWS WITH SPECIALIST
4.5 ANALYIS AND RECOMMENDATION
5 INTELLECTUAL PROPERTY (IP) PORTFOLIO
5.1 PATENT QUALITY AND STRENGTH
5.2 PATENT FAMILIES
5.3 LICENSING AND COLLABORATIONS
5.4 COMPETITIVE LANDSCAPE
5.5 IP STRATEGY AND MANAGEMENT
5.6 OTHER
6 COST ANALYSIS BREAKDOWN
7 TECHNONLOGY ROADMAP
8 INNOVATION TRACKER AND STRATEGIC ANALYSIS
8.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
8.1.1 JOINT VENTURES
8.1.2 MERGERS AND ACQUISITIONS
8.1.3 LICENSING AND PARTNERSHIP
8.1.4 TECHNOLOGY COLLABORATIONS
8.1.5 STRATEGIC DIVESTMENTS
8.2 NUMBER OF PRODUCTS IN DEVELOPMENT
8.3 INNOVATION STRATEGIES AND METHODOLOGIES
8.4 FUTURE OUTLOOK
9 REGULATORY COMPLIANCE
9.1 REGULATORY AUTHORITIES
9.2 REGULATORY CLASSIFICATIONS
9.3 REGULATORY SUBMISSIONS
9.4 INTERNATIONAL HARMONIZATION
9.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
9.6 REGULATORY CHALLENGES AND STRATEGIES
10 HEALTHCARE ECONOMY
11 GLOBAL PATIENT SIMULATORS MARKET, BY TYPE
11.1 OVERVIEW
11.2 HUMAN SIMULATOR
11.3 MANIKIN SIMULATOR
11.3.1 HIGH-FIDELITY SIMULATOR
11.3.2 PROCEDURAL SIMULATOR
11.3.2.1. TORSO SIMULATOR
11.3.2.2. PELVIS SIMULATOR
11.3.2.3. ARM SIMULATORS
11.4 VIRTUAL SIMULATOR
11.4.1 HYBRID SIMULAT
11.4.2 LARGE-SCALE SIMULAT
12 GLOBAL PATIENT SIMULATORS MARKET, BY TECHNOLOGY
12.1 OVERVIEW
12.2 AUGMENTED REALITY (AR) SIMULATORS
12.3 COMPUTER-BASED TRAINING
12.4 VIRTUAL REALITY (VR) SIMULATORS
13 GLOBAL PATIENT SIMULATORS MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 EDUCATION AND TRAINING
13.2.1 MEDICAL
13.2.2 NURSING
13.3 EMERGENCY MEDICAL SERVICES
13.4 MILITARY AND EMERGENCY PREPAREDNESS
13.5 OTHERS
14 GLOBAL PATIENT SIMULATORS MARKET, BY MEDICAL FIELD
14.1 OVERVIEW
14.2 EMERGENCY MEDICINE
14.3 ANESTHESIOLOGY
14.4 OBSTETRICS AND GYNECOLOGY
14.5 PEDIATRICS
14.6 INTERNAL MEDICINE
14.7 ORTHOPEDICS AND TRAUMA
14.8 RESPIRATORY
14.9 OTHER
15 GLOBAL PATIENT SIMULATORS MARKET, BY PRICE
15.1 OVERVIEW
15.2 60 USD – 420 USD
15.3 420 USD – 600 USD
15.4 600 USD – 1,200 USD
15.5 1,200 USD – 1,800 USD
15.6 OVER 2,400 USD
16 GLOBAL PATIENT SIMULATORS MARKET, BY END USER
16.1 OVERVIEW
16.2 ACADEMIC INSTITUTES
16.3 HOSPITALS AND CLINICS
16.4 AMBULATORY SURGICAL CENTERS
16.5 EMERGENCY MEDICAL SERVICES PROVIDERS
16.6 MILITARY ORGANIZATIONS
16.7 ACADEMIC AND RESEARCH INSTITUTES
16.8 OTHERS
17 GLOBAL PATIENT SIMULATORS MARKET, BY DISTRIBUTION CHANNEL
17.1 OVERVIEW
17.2 DIRECT TENDER
17.3 RETAIL SALES
17.3.1 OFFLINE
17.3.2 ONLINE
17.4 OTHERS
18 GLOBAL PATIENT SIMULATORS MARKET, SWOT AND DBMR ANALYSIS
19 GLOBAL PATIENT SIMULATORS MARKET, BY REGION
GLOBAL PATIENT SIMULATORS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
19.1 NORTH AMERICA
19.1.1 U.S.
19.1.1.1. U.S. PATIENT SIMULATORS MARKET, BY TYPE
19.1.1.2. U.S. PATIENT SIMULATORS MARKET, BY TECHNOLOGY
19.1.1.3. U.S. PATIENT SIMULATORS MARKET, BY APPLICATION
19.1.1.4. U.S. PATIENT SIMULATORS MARKET, BY MEDICAL FIELD
19.1.1.5. U.S. PATIENT SIMULATORS MARKET, BY PRICE
19.1.1.6. U.S. PATIENT SIMULATORS MARKET, BY END USER
19.1.1.7. U.S. PATIENT SIMULATORS MARKET, BY DISTRIBUTION CHANNEL
19.1.2 CANADA
19.1.3 MEXICO
19.2 EUROPE
19.2.1 GERMANY
19.2.2 FRANCE
19.2.3 U.K.
19.2.4 ITALY
19.2.5 SPAIN
19.2.6 RUSSIA
19.2.7 TURKEY
19.2.8 BELGIUM
19.2.9 NETHERLANDS
19.2.10 SWITZERLAND
19.2.11 REST OF EUROPE
19.3 ASIA-PACIFIC
19.3.1 JAPAN
19.3.2 CHINA
19.3.3 SOUTH KOREA
19.3.4 INDIA
19.3.5 AUSTRALIA
19.3.6 SINGAPORE
19.3.7 THAILAND
19.3.8 MALAYSIA
19.3.9 INDONESIA
19.3.10 PHILIPPINES
19.3.11 REST OF ASIA-PACIFIC
19.4 SOUTH AMERICA
19.4.1 BRAZIL
19.4.2 ARGENTINA
19.4.3 REST OF SOUTH AMERICA
19.5 MIDDLE EAST AND AFRICA
19.5.1 SOUTH AFRICA
19.5.2 SAUDI ARABIA
19.5.3 UAE
19.5.4 EGYPT
19.5.5 ISRAEL
19.5.6 REST OF MIDDLE EAST AND AFRICA
19.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
20 GLOBAL PATIENT SIMULATORS MARKET, COMPANY LANDSCAPE
20.1 COMPANY SHARE ANALYSIS: GLOBAL
20.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
20.3 COMPANY SHARE ANALYSIS: EUROPE
20.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
20.5 MERGERS & ACQUISITIONS
20.6 NEW PRODUCT DEVELOPMENT & APPROVALS
20.7 EXPANSIONS
20.8 REGULATORY CHANGES
20.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
21 GLOBAL PATIENT SIMULATORS MARKET, SWOT AND DBMR ANALYSIS
22 GLOBAL PATIENT SIMULATORS MARKET, COMPANY PROFILE
22.1 GEEKY MEDICS
22.1.1 COMPANY OVERVIEW
22.1.2 REVENUE ANALYSIS
22.1.3 GEOGRAPHIC PRESENCE
22.1.4 PRODUCT PORTFOLIO
22.1.5 RECENT DEVELOPMENTS
22.2 LAERDAL MEDICAL
22.2.1 COMPANY OVERVIEW
22.2.2 REVENUE ANALYSIS
22.2.3 GEOGRAPHIC PRESENCE
22.2.4 PRODUCT PORTFOLIO
22.2.5 RECENT DEVELOPMENTS
22.3 CAE HEALTHCARE
22.3.1 COMPANY OVERVIEW
22.3.2 REVENUE ANALYSIS
22.3.3 GEOGRAPHIC PRESENCE
22.3.4 PRODUCT PORTFOLIO
22.3.5 RECENT DEVELOPMENTS
22.4 GAUMARD SCIENTIFIC
22.4.1 COMPANY OVERVIEW
22.4.2 REVENUE ANALYSIS
22.4.3 GEOGRAPHIC PRESENCE
22.4.4 PRODUCT PORTFOLIO
22.4.5 RECENT DEVELOPMENTS
22.5 SURGICAL SCIENCE SWEDEN AB
22.5.1 COMPANY OVERVIEW
22.5.2 REVENUE ANALYSIS
22.5.3 GEOGRAPHIC PRESENCE
22.5.4 PRODUCT PORTFOLIO
22.5.5 RECENT DEVELOPMENTS
22.6 SIMULAB CORPORATION
22.6.1 COMPANY OVERVIEW
22.6.2 REVENUE ANALYSIS
22.6.3 GEOGRAPHIC PRESENCE
22.6.4 PRODUCT PORTFOLIO
22.6.5 RECENT DEVELOPMENTS
22.7 3D SYSTEMS
22.7.1 COMPANY OVERVIEW
22.7.2 REVENUE ANALYSIS
22.7.3 GEOGRAPHIC PRESENCE
22.7.4 PRODUCT PORTFOLIO
22.7.5 RECENT DEVELOPMENTS
22.8 ADAM, ROUILLY LTD.
22.8.1 COMPANY OVERVIEW
22.8.2 REVENUE ANALYSIS
22.8.3 GEOGRAPHIC PRESENCE
22.8.4 PRODUCT PORTFOLIO
22.8.5 RECENT DEVELOPMENTS
22.9 SIMULAIDS
22.9.1 COMPANY OVERVIEW
22.9.2 REVENUE ANALYSIS
22.9.3 GEOGRAPHIC PRESENCE
22.9.4 PRODUCT PORTFOLIO
22.9.5 RECENT DEVELOPMENTS
22.1 MENTICE AB
22.10.1 COMPANY OVERVIEW
22.10.2 REVENUE ANALYSIS
22.10.3 GEOGRAPHIC PRESENCE
22.10.4 PRODUCT PORTFOLIO
22.10.5 RECENT DEVELOPMENTS
22.11 SIMX
22.11.1 COMPANY OVERVIEW
22.11.2 REVENUE ANALYSIS
22.11.3 GEOGRAPHIC PRESENCE
22.11.4 PRODUCT PORTFOLIO
22.11.5 RECENT DEVELOPMENTS
22.12 KOKEN CO. LTD.
22.12.1 COMPANY OVERVIEW
22.12.2 REVENUE ANALYSIS
22.12.3 GEOGRAPHIC PRESENCE
22.12.4 PRODUCT PORTFOLIO
22.12.5 RECENT DEVELOPMENTS
22.13 BODY INTERACT
22.13.1 COMPANY OVERVIEW
22.13.2 REVENUE ANALYSIS
22.13.3 GEOGRAPHIC PRESENCE
22.13.4 PRODUCT PORTFOLIO
22.13.5 RECENT DEVELOPMENTS
22.14 BMC MEDICAL
22.14.1 COMPANY OVERVIEW
22.14.2 REVENUE ANALYSIS
22.14.3 GEOGRAPHIC PRESENCE
22.14.4 PRODUCT PORTFOLIO
22.14.5 RECENT DEVELOPMENTS
22.15 LIFECAST BODY SIMULATION LTD
22.15.1 COMPANY OVERVIEW
22.15.2 REVENUE ANALYSIS
22.15.3 GEOGRAPHIC PRESENCE
22.15.4 PRODUCT PORTFOLIO
22.15.5 RECENT DEVELOPMENTS
22.16 FLUKE
22.16.1 COMPANY OVERVIEW
22.16.2 REVENUE ANALYSIS
22.16.3 GEOGRAPHIC PRESENCE
22.16.4 PRODUCT PORTFOLIO
22.16.5 RECENT DEVELOPMENTS
22.17 MEDICAL-X
22.17.1 COMPANY OVERVIEW
22.17.2 REVENUE ANALYSIS
22.17.3 GEOGRAPHIC PRESENCE
22.17.4 PRODUCT PORTFOLIO
22.17.5 RECENT DEVELOPMENTS
22.18 LIMBS & THINGS LTD
22.18.1 COMPANY OVERVIEW
22.18.2 REVENUE ANALYSIS
22.18.3 GEOGRAPHIC PRESENCE
22.18.4 PRODUCT PORTFOLIO
22.18.5 RECENT DEVELOPMENTS
22.19 KYOTO KAGAKU CO. LTD.
22.19.1 COMPANY OVERVIEW
22.19.2 REVENUE ANALYSIS
22.19.3 GEOGRAPHIC PRESENCE
22.19.4 PRODUCT PORTFOLIO
22.19.5 RECENT DEVELOPMENTS
22.2 VIRTAMED AG.
22.20.1 COMPANY OVERVIEW
22.20.2 REVENUE ANALYSIS
22.20.3 GEOGRAPHIC PRESENCE
22.20.4 PRODUCT PORTFOLIO
22.20.5 RECENT DEVELOPMENTS
22.21 3-DMED LEARNING THROUGH SIMULATION
22.21.1 COMPANY OVERVIEW
22.21.2 REVENUE ANALYSIS
22.21.3 GEOGRAPHIC PRESENCE
22.21.4 PRODUCT PORTFOLIO
22.21.5 RECENT DEVELOPMENTS
22.22 SKILLUP
22.22.1 COMPANY OVERVIEW
22.22.2 REVENUE ANALYSIS
22.22.3 GEOGRAPHIC PRESENCE
22.22.4 PRODUCT PORTFOLIO
22.22.5 RECENT DEVELOPMENTS
22.23 INTELLIGENT ULTRASOUND
22.23.1 COMPANY OVERVIEW
22.23.2 REVENUE ANALYSIS
22.23.3 GEOGRAPHIC PRESENCE
22.23.4 PRODUCT PORTFOLIO
22.23.5 RECENT DEVELOPMENTS
22.24 INOVUS LIMITED
22.24.1 COMPANY OVERVIEW
22.24.2 REVENUE ANALYSIS
22.24.3 GEOGRAPHIC PRESENCE
22.24.4 PRODUCT PORTFOLIO
22.24.5 RECENT DEVELOPMENTS
22.25 HRV SIMULATION.
22.25.1 COMPANY OVERVIEW
22.25.2 REVENUE ANALYSIS
22.25.3 GEOGRAPHIC PRESENCE
22.25.4 PRODUCT PORTFOLIO
22.25.5 RECENT DEVELOPMENTS
22.26 NASCO HEALTHCARE
22.26.1 COMPANY OVERVIEW
22.26.2 REVENUE ANALYSIS
22.26.3 GEOGRAPHIC PRESENCE
22.26.4 PRODUCT PORTFOLIO
22.26.5 RECENT DEVELOPMENTS
22.27 SYNAPTIVE MEDICAL INC
22.27.1 COMPANY OVERVIEW
22.27.2 REVENUE ANALYSIS
22.27.3 GEOGRAPHIC PRESENCE
22.27.4 PRODUCT PORTFOLIO
22.27.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
23 QUESTIONNAIRE
24 RELATED REPORT
25 CONCLUSION
26 ABOUT DATA BRIDGE MARKET RESEARCH
